Abstract：
OBJECTIVE: To compare the clinical effect of intradermal needling and acupuncture in prevention and treatment of leukopenia after chemotherapy with spleen-kidney deficiency.
METHODS: A total of 90 patients with malignant tumor who received chemotherapy were randomly divided into a intradermal needling group (30 cases, 1 case dropped out), an acupuncture group (30 cases, 2 cases dropped out, 1 case was eliminated) and a control group (30 cases). The control group received conventional symptomatic treatment after chemotherapy. On the basis of the treatment in the control group, the intradermal needling group received intradermal needling at Guanyuan (CV 4), Dazhui (GV 14) and bilateral Geshu (BL 17), Zusanli (ST 36)，Shenshu (BL 23), the needles were retained for 48 h, once every other day. On the basis of the treatment in the control group, the acupuncture group received conventional acupuncture at the same acupoints as the intradermal needling group, once every other day. The treatment started from the first day of chemotherapy, for a total of 2 weeks in the three groups. The white blood cell count, neutrophil count, hemoglobin content, platelet count and Karnofsky performance status (KPS) score before treatment and on 3rd, 7th, 14th, and 21st days after treatment were compared among the three groups. The incidence and grading of leukopenia and the usage of leukocyte-boosting drug during chemotherapy cycle was recorded.
RESULTS: On 7th day after treatment, the white blood cell count in the intradermal needling group and the acupuncture group was higher than that in the control group (P<0.01, P<0.05). On the 14th day after treatment, the hemoglobin content in the intradermal needling group and the acupuncture group was higher than that in the control group (P<0.01). On the 7th, 14th, and 21st days after treatment, the platelet count in the acupuncture group was higher than that in the control group (P<0.01), on the 14th and 21st days after treatment, the platelet count in the intradermal needling group was higher than that in the control group (P<0.01). There was no statistically significant difference among the three groups after treatment in terms of neutrophil count, KPS score, incidence and grading of leukopenia, and the usage of leukocyte-boosting drug (P>0.05).
CONCLUSIONS: Both intradermal needling and acupuncture can effectively increase peripheral blood white blood cell count, hemoglobin content and platelet count during chemotherapy cycle, reduce the toxicity of chemotherapy drug to bone marrow hematopoietic function, and alleviate bone marrow suppression after chemotherapy. The two treatments are equally effective.
目的：比较揿针和针刺防治脾肾两虚型化疗后白细胞减少症的临床疗效。方法：将90例接受化疗的恶性肿瘤患者随机分为揿针组（30例，脱落1例）、针刺组（30例，脱落2例，剔除1例）和对照组（30例）。对照组在化疗的基础上予常规对症治疗；在对照组治疗基础上，揿针组于关元、大椎及双侧膈俞、足三里、肾俞行揿针治疗，留针48 h，隔日1次；在对照组治疗基础上，针刺组于揿针组相同穴位行常规针刺治疗，隔日1次。均从化疗第1天开始，共治疗2周。比较各组患者治疗前及治疗第3、7、14、21天白细胞计数、中性粒细胞计数、血红蛋白含量、血小板计数、Karnofsky功能状态（KPS）评分；于治疗第21天评定白细胞减少症的分度、发生率，记录化疗周期中升白细胞药物使用情况。结果：治疗第7天，揿针组和针刺组白细胞计数高于对照组（P<0.01，P<0.05）。治疗第14天，揿针组和针刺组血红蛋白含量高于对照组（P<0.01）。治疗第7、14、21天，针刺组血小板计数高于对照组（P<0.01），治疗第14、21天，揿针组血小板计数高于对照组（P<0.01）。各组治疗后各时间点中性粒细胞计数、KPS评分及白细胞减少症分度、白细胞减少症发生率、升白细胞药物使用情况比较，差异无统计学意义（P>0.05）。结论：揿针和常规针刺在化疗周期中均可升高外周血白细胞计数、血红蛋白含量、血小板计数，减少化疗药物对骨髓造血功能的影响，减轻化疗后骨髓抑制，两种治疗方法疗效相当。.
METHODS: A total of 90 patients with malignant tumor who received chemotherapy were randomly divided into a intradermal needling group (30 cases, 1 case dropped out), an acupuncture group (30 cases, 2 cases dropped out, 1 case was eliminated) and a control group (30 cases). The control group received conventional symptomatic treatment after chemotherapy. On the basis of the treatment in the control group, the intradermal needling group received intradermal needling at Guanyuan (CV 4), Dazhui (GV 14) and bilateral Geshu (BL 17), Zusanli (ST 36)，Shenshu (BL 23), the needles were retained for 48 h, once every other day. On the basis of the treatment in the control group, the acupuncture group received conventional acupuncture at the same acupoints as the intradermal needling group, once every other day. The treatment started from the first day of chemotherapy, for a total of 2 weeks in the three groups. The white blood cell count, neutrophil count, hemoglobin content, platelet count and Karnofsky performance status (KPS) score before treatment and on 3rd, 7th, 14th, and 21st days after treatment were compared among the three groups. The incidence and grading of leukopenia and the usage of leukocyte-boosting drug during chemotherapy cycle was recorded.
RESULTS: On 7th day after treatment, the white blood cell count in the intradermal needling group and the acupuncture group was higher than that in the control group (P<0.01, P<0.05). On the 14th day after treatment, the hemoglobin content in the intradermal needling group and the acupuncture group was higher than that in the control group (P<0.01). On the 7th, 14th, and 21st days after treatment, the platelet count in the acupuncture group was higher than that in the control group (P<0.01), on the 14th and 21st days after treatment, the platelet count in the intradermal needling group was higher than that in the control group (P<0.01). There was no statistically significant difference among the three groups after treatment in terms of neutrophil count, KPS score, incidence and grading of leukopenia, and the usage of leukocyte-boosting drug (P>0.05).
CONCLUSIONS: Both intradermal needling and acupuncture can effectively increase peripheral blood white blood cell count, hemoglobin content and platelet count during chemotherapy cycle, reduce the toxicity of chemotherapy drug to bone marrow hematopoietic function, and alleviate bone marrow suppression after chemotherapy. The two treatments are equally effective.
目的：比较揿针和针刺防治脾肾两虚型化疗后白细胞减少症的临床疗效。方法：将90例接受化疗的恶性肿瘤患者随机分为揿针组（30例，脱落1例）、针刺组（30例，脱落2例，剔除1例）和对照组（30例）。对照组在化疗的基础上予常规对症治疗；在对照组治疗基础上，揿针组于关元、大椎及双侧膈俞、足三里、肾俞行揿针治疗，留针48 h，隔日1次；在对照组治疗基础上，针刺组于揿针组相同穴位行常规针刺治疗，隔日1次。均从化疗第1天开始，共治疗2周。比较各组患者治疗前及治疗第3、7、14、21天白细胞计数、中性粒细胞计数、血红蛋白含量、血小板计数、Karnofsky功能状态（KPS）评分；于治疗第21天评定白细胞减少症的分度、发生率，记录化疗周期中升白细胞药物使用情况。结果：治疗第7天，揿针组和针刺组白细胞计数高于对照组（P<0.01，P<0.05）。治疗第14天，揿针组和针刺组血红蛋白含量高于对照组（P<0.01）。治疗第7、14、21天，针刺组血小板计数高于对照组（P<0.01），治疗第14、21天，揿针组血小板计数高于对照组（P<0.01）。各组治疗后各时间点中性粒细胞计数、KPS评分及白细胞减少症分度、白细胞减少症发生率、升白细胞药物使用情况比较，差异无统计学意义（P>0.05）。结论：揿针和常规针刺在化疗周期中均可升高外周血白细胞计数、血红蛋白含量、血小板计数，减少化疗药物对骨髓造血功能的影响，减轻化疗后骨髓抑制，两种治疗方法疗效相当。.
摘要：
暂无翻译
